Early Evidence of Inactivated Enterovirus 71 Vaccine Impact Against Hand, Foot, and Mouth Disease in a Major Center of Ongoing Transmission in China, 2011–2018: A Longitudinal Surveillance Study. (27th December 2019)

• Record Type: Journal Article
• Authors: Head, Jennifer R; Collender, Philip A; Lewnard, Joseph A; Skaff, Nicholas K; Li, Ling; Cheng, Qu; Baker, Julia M; Li, Charles; Chen, Dehao; Ohringer, Alison; Liang, Song; Yang, Changhong; Hubbard, Alan; Lopman, Benjamin; Remais, Justin V
• Is Part Of: Clinical infectious diseases. Volume 71:Number 12(2020)
• Page Start: 3088
• Page End: 3095
• Publication Date: 2019-12-27
• Subjects: hand, foot, and mouth disease -- enterovirus -- EV71 -- vaccine -- China; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciz1188
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: Enterovirus 71 (EV71) is a major causative agent of hand, foot, and mouth disease (HFMD), associated with severe manifestations of the disease. Pediatric immunization with inactivated EV71 vaccine was initiated in 2016 in the Asia-Pacific region, including China. We analyzed a time series of HFMD cases attributable to EV71, coxsackievirus A16 (CA16), and other enteroviruses in Chengdu, a major transmission center in China, to assess early impacts of immunization. Methods: Reported HFMD cases were obtained from China's notifiable disease surveillance system. We compared observed postvaccination incidence rates during 2017–2018 with counterfactual predictions made from a negative binomial regression and a random forest model fitted to prevaccine years (2011–2015). We fit a change point model to the full time series to evaluate whether the trend of EV71 HFMD changed following vaccination. Results: Between 2011 and 2018, 279 352 HFMD cases were reported in the study region. The average incidence rate of EV71 HFMD in 2017–2018 was 60% (95% prediction interval [PI], 41%–72%) lower than predicted in the absence of immunization, corresponding to an estimated 6911 (95% PI, 3246–11 542) EV71 cases averted over 2 years. There were 52% (95% PI, 42%–60%) fewer severe HFMD cases than predicted. However, the incidence rate of non-CA16 and non-EV71 HFMD was elevated in 2018. We identified a significant decline in the trend of EV71 HFMD 4 months into the postvaccine period. Conclusions: We provide the first real-world evidence that programmatic vaccination against EV71 is effective against childhood HFMD and present an approach to detect early vaccine impact or intended consequences from surveillance data. Abstract : The number of cases of severe hand, foot, and mouth disease (HFMD) and enterovirus 71 (EV71) declined by an estimated 52% and 60%, respectively, following initiation of a pediatric EV71 immunization program in Chengdu, China.